Skip to main content

Alaunos Therapeutics, Inc.

TCRT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001107421

No open-market purchases or sales by Alaunos Therapeutics, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $204.4K in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Alaunos Therapeutics, Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of TCRT: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders9286−6
Shares56.1M41.3M−14.8M (−26.4%)
Value$7.36M$2.96M−$4.41M (−59.8%)

New holders (9)

Institutions that held Alaunos Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to TCRT in Q4 2023
InstitutionSharesValue% of portfolio
Squarepoint Ops LLC446,258$31.6K0.00%
Renaissance Technologies LLC382,000$27.0K0.00%
Millennium Management LLC100,730$7.12K0.00%
Redwood Wealth Management Group, LLC50,100$3.54K0.00%
StoneX Group Inc.34,000$2.40K0.00%
LPL Financial LLC23,431$1.66K0.00%
Fielder Capital Group LLC15,000$1.06K0.00%
Mesirow Financial Investment Management, Inc.14,000$9900.00%
Tidemark, LLC400$280.00%

Sold out (15)

Institutions that held Alaunos Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.